PDK1 and essential thrombocythemia: Of note, mTOR signaling appears to be inhibited in CALR-mutated ET patients, as demonstrated by the downregulation of the mTOR2 complex subunit RICTOR, and of several upstream and downstream factors (i.e., PDK1, PHIP, RHEB, PP2A, and RPS6KB1) (Fig. 2a).